| Life Sciences Tools & Services Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| KR Country | 41 Employees | - Last Dividend | - Last Split | - IPO Date |
Celemics, Inc., founded in 2010 and based in Seoul, South Korea, specializes in the design, manufacture, and distribution of sequencing kits. This innovative company leverages cutting-edge technology to provide comprehensive solutions in the field of genetic analysis and sequencing. Through its broad range of products and services, Celemics aids research and clinical applications, targeting both hereditary and somatic mutations associated with cancer, among other genomic studies.
These kits are tailored for the precise detection of mutations within the BRCA1 and BRCA2 genes, known for their association with increased risks of breast and ovarian cancer. They provide essential tools for genetic research and screening in Oncology.
Designed for the identification of mutations that occur in somatic cells, which can lead to cancer. These kits enable researchers and clinicians to detect and study these mutations, offering insights necessary for the development of targeted therapies.
These kits focus on the genetic variants that predispose individuals to a range of hereditary cancers. By facilitating early detection and risk assessment, they play a crucial role in preventive healthcare strategies.
Essential for preparing samples for Next Generation Sequencing (NGS), these kits streamline the workflow by providing all required reagents and protocols. They are critical for ensuring high-quality data generation from genomic DNA or RNA samples.
Celemics offers tailor-made solutions with its customized target enrichment kits, which allow for the selective sequencing of specific genomic regions of interest, enhancing efficiency and reducing sequencing costs.
Providing comprehensive sequencing services, Celemics facilitates the entire NGS workflow from sample preparation to data analysis, catering to the needs of academic, clinical, and research laboratories.
To support laboratories and institutions in setting up or upgrading their NGS capabilities, Celemics offers consulting services that cover laboratory design, equipment selection, workflow management, and personnel training, ensuring an optimized and efficient sequencing facility.